A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Advances in AI, genomics, and liquid biopsy are reshaping cancer care, but systemic gaps persist in access and funding, ...

Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively ...

Microscopic command centers in our bodies called primary cilia—once thought irrelevant—could be hidden switches powering ...

Adoptive cell therapy based on ex-vivo expanded tumor-infiltrating lymphocytes (TILs) has historically been most effective in ...

Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

This paper investigates how isoform II of transcription factor RUNX2 promotes cell survival and proliferation in oral squamous cell carcinoma cell lines. The authors used gain and loss of function ...

The researchers found that linoleic acid binds to a protein called FABP5 (fatty acid-binding protein 5), which is at high levels in these cancer cells. In the new study, mice fed a high linoleic-acid ...

Vitamin D has been shown to reduce inflammation, promote the death of cancer cells, inhibit tumor growth and enhance immune response, the researchers found. "These mechanisms significantly ...

Now visualized using cryo-electron microscopy, the carrier’s lock-like mechanism could be the key to tackling diseases like cancer, diabetes, and even hair loss. By blocking or modifying this gateway, ...